No Direct Nebulized Equivalent for QVAR (Beclomethasone Dipropionate) Inhaler
There is no specific nebulized formulation of beclomethasone dipropionate (QVAR) available as a direct equivalent, and nebulized corticosteroids are generally not recommended when the same medication can be delivered via hand-held inhalers. 1
Rationale for Not Using Nebulized Corticosteroids
The European Respiratory Society guidelines on nebulizer use clearly state that nebulized corticosteroids have been used as substitutes for oral corticosteroids in various situations, but "in each of these situations, an equivalent dose of inhaled steroid could be given more easily by the use of a hand-held inhaler" 1. This recommendation is based on clinical evidence and practical considerations.
The British Thoracic Society similarly notes that there are limited published randomized controlled trials on nebulized corticosteroids in adults with asthma, and recommends that patients should be reviewed by a respiratory specialist before being prescribed nebulized corticosteroids 1.
Clinical Considerations
When considering alternatives to QVAR inhaler:
Hand-held inhaler with spacer is preferred:
For patients unable to use hand-held inhalers:
Dose considerations:
- If transitioning from QVAR to a nebulized corticosteroid is necessary, a 2:1 dose ratio (nebulized:MDI) may be appropriate based on limited studies 3
- For example, 800 mcg of nebulized beclomethasone might be roughly equivalent to 400 mcg via MDI with spacer
Common Pitfalls to Avoid
Unnecessary nebulization: Nebulizers require more time for administration, are less portable, more expensive, and may deliver inconsistent doses compared to properly used inhalers with spacers
Infection risk: Nebulizers can become contaminated and require proper cleaning and maintenance 1
Mixing medications: The practice of mixing nebulized corticosteroids with bronchodilators cannot be recommended without further evidence 2
Overreliance on nebulizers: For long-term asthma management, hand-held inhalers are as effective as nebulizers, making it unusual for a patient to require long-term nebulized corticosteroid therapy 1
If a patient cannot use QVAR inhaler effectively, the most appropriate approach would be to:
- Assess inhaler technique and consider adding a spacer device
- Consider alternative hand-held inhaler devices that might be easier for the patient to use
- Only if absolutely necessary, consult with a respiratory specialist about the possibility of using nebulized budesonide as an alternative corticosteroid delivery method